Results & Reactions from the First National A3 Collaborative Cohort

This past March marked the end of the initial A3 Collaborative, culminating in a celebration of organizations’ advancements and showcasing results from the 12-month learning experience. Teams shared a broad range of performance outcomes ranging from internal structure and process improvements, to clinical outcomes improvements, to reductions in hospital readmissions. Results such as: reducing 90-day readmissions by 59%; in another example: a net Return on Investment (ROI) of $486,304 (141%); and a third: total cost avoided of $870,000. As AIMM readies to launch the 2018/2019 A3 Collaborative, we are hearing from participating individuals: “the collaborative creates a learning experience that optimizes the potential to learn from other pharmacists and systems who may be on the same path of improvement but at different stages. This sharing of knowledge has been key to my progress…”